Artia Global Partners LP Verona Pharma PLC Transaction History
Artia Global Partners LP
- $395 Billion
- Q1 2025
A detailed history of Artia Global Partners LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Artia Global Partners LP holds 538,488 shares of VRNA stock, worth $56.7 Million. This represents 8.65% of its overall portfolio holdings.
Number of Shares
538,488
Previous 255,318
110.91%
Holding current value
$56.7 Million
Previous $11.9 Billion
188.34%
% of portfolio
8.65%
Previous 4.24%
Shares
6 transactions
Others Institutions Holding VRNA
# of Institutions
302Shares Held
74MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$691 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$581 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$413 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$364 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$305 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.42B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...